RecruitingNCT07315386
Catatonic Syndrome in Adult Patients at Basurto Hospital: A Descriptive Study of Incidence, Comorbidity, and Short-Term Outcomes
Sponsor
Beatriz Rodriguez Cabo
Enrollment
40 participants
Start Date
Jan 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to assess the incidence, sociodemographic and clinical characteristics, treatment response, and short-term outcomes of adult patients with catatonic syndrome in the Bilbao area (Spain). Data will be collected from January 2024 to December 2025 from all patients aged 18 years or older diagnosed with catatonia of any etiology at Basurto University Hospital who provide informed consent to participate.
Eligibility
Min Age: 18 Years
Inclusion Criteria6
- Age ≥ 18 years at the time of hospital care.
- Diagnosis of catatonic syndrome established according to DSM-5 criteria.
- Patients attended at Basurto University Hospital in any clinical setting, including the Emergency Department or inpatient physical or psychiatric units.
- Diagnosis made during the study period, from 1 January 2024 to 31 December 2025.
- Catatonia of any etiology, including psychiatric, neurological, medical, metabolic, toxic, or autoimmune causes.
- Provision of informed consent by the patient or their legal representative, when clinically feasible; deferred consent accepted in cases of acute catatonia.
Exclusion Criteria2
- Refusal to participate in the study by the patient or their legal representative.
- Withdrawal of informed consent at any point during the study.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07315386